|
2008 Conference Publication Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney diseaseGobe, GC, Vesey, DA, Bennett, NC and Johnson, DW (2008). Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease. 11th Asian Pacific Congress of Nephrology, incorporating the 15th Asian Colloquium in Nephrology and 2nd Asian Forum of CKD Initiative, Kuala Lumpur, Malaysia, 5–8 May 2008. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00953.x |
|
2008 Conference Publication Recombinant human erythropoietin increases vascular expression of Nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injuryGobe, G., Bennett, N., Patel, J., Yamada, M., Colditz, P. and Johnson, D. (2008). Recombinant human erythropoietin increases vascular expression of Nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Newcastle, Australia, 6-10 September 2008. Hoboken, NJ, United States: Wiley-Blackwell. |
|
2008 Conference Publication Recombinant human erythropoietin increases vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injuryGobe, G. C., Yamada, M., Vesey, D. A. and Johnson, D. W. (2008). Recombinant human erythropoietin increases vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury. 11th Asian-Pacific Congress of Nephrology, Kuala Lumpur, Malaysia, 5–8 May 2008. Carlton, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00954.x |
|
2008 Conference Publication Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney diseaseGobe, G. C., Vesey, D. A., Bennett, N. C. and Johnson, D. W. (2008). Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease. 11th Asian Pacific Congress of Nephrology (APCN), Kuala Lumpur, Malaysia, 4-7 May 2008. Carlton, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00953.x |
|
2008 Conference Publication Implementation of the routine reporting of eGFR in Australia and New ZealandJones, Graham R. D., Mathew, Timothy, Johnson, David and Peake, Michael (2008). Implementation of the routine reporting of eGFR in Australia and New Zealand. 11th Bergmeyer Conference, Eibsee, 2008. Taylor & Francis. doi: 10.1080/00365510802144953 |
|
2008 Conference Publication Immuno-histochemical profiling of clear cell renal cell carcinoma: A tissue microarray studyRajandram, R., Perry-Keene, J., Campbell, C., Johnson, D. and Gobe, G. (2008). Immuno-histochemical profiling of clear cell renal cell carcinoma: A tissue microarray study. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Newcastle, Australia, 6-10 September 2008. Carlton, Australia: Blackwell. doi: 10.1111/j.1440-1797.2008.001013.x |
|
2008 Conference Publication Immunotherapy and radiation increase apoptosis in renal cell carcinoma: Identification of potential diagnostic markersRajandram, R., Pat, B. K., Percy, C. J., Johnson, D. W. and Gobe, G. C. (2008). Immunotherapy and radiation increase apoptosis in renal cell carcinoma: Identification of potential diagnostic markers. 11th Asian Pacific Congress of Nephrology (APCN), Kuala Lumpur, Malaysia, 5-8 May 2008. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00954.x |
|
2008 Conference Publication Adiponectin is associated with cardiovascular disease in renal transplant recipients: Baseline results from the LANDMARK 2 studyKaisar, Mohd, Armstrong, Kirsten, Hawley, Carmel, Campbell, Scott, Mudge, David, Johnson, David, Prins, John and Isbel, Nicole (2008). Adiponectin is associated with cardiovascular disease in renal transplant recipients: Baseline results from the LANDMARK 2 study. 8th American Transplant Congress, Toronto, Canada, 31 May - 4 June 2008 . Hoboken, NJ, United States: Wiley-Blackwell . |
|
2008 Conference Publication Peroxisome proliferator-activated receptors (PPARs) in chronic kidney disease in ageingPercy, Christine, Brown, L., Johnson, D. W. and Gobe, G. (2008). Peroxisome proliferator-activated receptors (PPARs) in chronic kidney disease in ageing. Australian and New Zealand Society of Nephrology (ANZSN) Annual Conference, Newcastle, Australia, 6-10 September 2008. |
|
2008 Conference Publication Intradermal versus intramuscular hepatitis B vaccination in haemodialysis patients: A prospective, open label randomized controlled trial in patients unresponsive to primary vaccinationWiggins, K., Van Eps, C., Barraclough, K., Whitby, M., Carpenter, S., Johnson, D., Johnson, C. H. and Playford, G. (2008). Intradermal versus intramuscular hepatitis B vaccination in haemodialysis patients: A prospective, open label randomized controlled trial in patients unresponsive to primary vaccination. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Newcastle, Australia, 6–10 September 2008. Hoboken, NJ United States: Wiley-Blackwell. |
|
2007 Conference Publication Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patientsMollee, Peter, Hourigan, Matthew, Johnson, David, Jones, Mark, Isbel, Nikki, Hawley, Carmel, Marlton, Paula, Gandhi, Maher, Campbell, Scott and Gill, Devinder (2007). Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients. 49th Annual Meeting of the American-Society-of-Hematology, Atlanta, GA USA, 8-11 December 2007. Washington, DC USA: American Society of Hematology. |
|
2007 Conference Publication Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant PatientsHourigan, Matthew J., Johnson, David W., Jones, Mark, Gill, Devinder S., Isbel, Nikki, Hawley, Carmel M., Marlton, Paula, Ghandhi, Maher, Campbell, Scott B. and Mollee, Peter (2007). Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients. American Transplant Congress 2007, USA, 5-9 May 2007. UK: Wiley-Blackwell Publising Ltd.. doi: 10.1111/j.1600-6143.2007.01811.x |
|
2007 Conference Publication Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patientsHourigan, Matthew J., Johnson, David W., Jones, Mark, Gill, Devinder S., Isbel, Nikki, Hawley, Carmel M., Marlton, Paula, Gandhi, Maher, Campbell, Scott B. and Mollee, Peter (2007). Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients. American Transplant Congress, San Francisco, CA, USA, 5-9 May 2007. Oxford, England: Wiley-Blackwell. doi: 10.1111/j.1600-6143.2007.01811.x |
|
2007 Conference Publication Collapsing glomerulopathy secondary to human parvovirus b19 in a kidney-pancreas transplant recipientKaisar, M. O., Hawley, C. M., Mudge, D. W., Campbell, S. B., Johnson, D. W. and Isbel, N. M. (2007). Collapsing glomerulopathy secondary to human parvovirus b19 in a kidney-pancreas transplant recipient. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell. |
|
2007 Conference Publication MSC protect renal tubular epithelium from oxidative stress in vitro: support for a protective or regenerative role in acute renal failureLiu, H., McTaggart, S., Li, J., Johnson, D. W. and Gobe, G. C. (2007). MSC protect renal tubular epithelium from oxidative stress in vitro: support for a protective or regenerative role in acute renal failure. World Congress of Nephrology 2007, Rio de Janeiro, Brazil, 21-25 April 2007. International Society of Nephrology. |
|
2007 Conference Publication The molecular and cellular changes associated with ageing and disease in the kidneyPercy, C., Brown, L., Johnson, D. W., Power, D. and Gobe, G. C. (2007). The molecular and cellular changes associated with ageing and disease in the kidney. Australian Society of Medical Research Annual Scientific Meeting, Blue Mountains NSW, November, 2007. |
|
2007 Conference Publication Access infection in dialysis patients: A comparison of peritoneal vs haemodialysis in a large dialysis populationClark, C. J., Johnson, D., Hawley, C., May, K., Campbell, S., Isbel, N., Mudge, D. and Burke, J. (2007). Access infection in dialysis patients: A comparison of peritoneal vs haemodialysis in a large dialysis population. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell Publishing. |
|
2007 Conference Publication The molecular and cellular changes associated with ageing and disease in the kidneyPercy, C., Brown, L., Johnson, D. W., Power, D. and Gobe, G. C. (2007). The molecular and cellular changes associated with ageing and disease in the kidney. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8-12 September, 2007. |
|
2007 Conference Publication Intravenous versus oral iron supplementation in peritoneal dialysis patientsJohnson, David W. (2007). Intravenous versus oral iron supplementation in peritoneal dialysis patients. The 11th Congress of the International Society for Peritoneal Dialysis, Hong Kong, 25-29 August, 2006. Milton, Ontario: Multimed Inc.. |
|
2007 Conference Publication Follow-up of 15 years of live donors in a large Australian renal transplant unitKaisar, M. O., Isbel, N., Hawley, C., Johnson, D., Mudge, D., Griffin, A., Wall, D., Preston, J., Nicol, D. and Campbell, S. (2007). Follow-up of 15 years of live donors in a large Australian renal transplant unit. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell. |